Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer updates its ClinicalTrials.gov interface/revision version from v3.5.2 to v3.5.3, indicating a minor site build/version change rather than a study record change.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedA new study record version (v3.4.3) was added to the history, and the previous version (v3.4.2) was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedThe record history shows a new revision (v3.4.2) added and an older revision (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe record history shows a new revision (v3.4.1) added on 2026-02-04 with a 'Study Status' entry, and the prior revision (v3.4.0) removed on 2025-12-04. These are administrative updates to versioning and do not alter core trial data or visible user content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.